Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohort
2008 (English)In: Cancer Epidemiology, Biomarkers and Prevention, ISSN 1055-9965, Vol. 17, no 1, 249-251 p.Article in journal (Refereed) Published
Tumor molecular markers hold promise to distinguish potentially lethal from indolent prostate cancer and to guide treatment choices. A previous study identified a nine-gene molecular signature in tumors associated with prostate-specific antigen relapse after prostatectomy. We examined this molecular model in relation to prostate cancer death among 172 men with initially localized disease. We quantified protein expression of the nine genes in tumors to classify progression risk. Accounting for clinical prognostic factors, the nine-gene model did not provide discrimination to predict lethal and indolent prostate cancer.
Place, publisher, year, edition, pages
2008. Vol. 17, no 1, 249-251 p.
Medical and Health Sciences
IdentifiersURN: urn:nbn:se:uu:diva-89215DOI: 10.1158/1055-9965.EPI-07-0722ISI: 000252503900033PubMedID: 18199732OAI: oai:DiVA.org:uu-89215DiVA: diva2:159633